Timothy Alexander

Where the Creek Still Runs Free The trail narrows as it drops toward the water, the air cooling just enough to notice. Underfoot, damp leaves soften each step, and the sound of the […]

Podcasting Morning Chat Names Ralph Estep Jr. Co-Executive Producer MIDDLETOWN, DE — Podcasting Morning Chat has named Ralph Estep Jr. as co-executive producer alongside founder and host Marc Ronick to support the s […]

Aclaris Completes Enrollment in Phase 2 Trial of Bosakitug for Atopic Dermatitis WAYNE, PA — Aclaris Therapeutics Inc. (Nasdaq: ACRS) has completed patient enrollment in its Phase 2 trial of bosakitug in patients with m […]

Historic Germantown Launches Free Spring Events PHILADELPHIA, PA — Historic Germantown will launch a series of free public events beginning Tuesday, April 7, offering residents and visitors access t […]

InterDigital Report Examines Network Impact of Agentic AI Growth WILMINGTON, DE — InterDigital Inc. (Nasdaq: IDCC) and ABI Research have released a report examining how the rise of agentic artificial intelligence i […]

ArriVent to Present Preclinical Cancer Drug Data at AACR 2026 NEWTOWN SQUARE, PA — ArriVent BioPharma Inc. (Nasdaq: AVBP) will present preclinical data on two cancer drug candidates at the American Association f […]

Neuronetics Reports Higher Revenue, Narrows Loss, Sets 2026 Outlook MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) reported higher fourth-quarter and full-year 2025 revenue, narrowed its losses, posted positive o […]

Prelude Therapeutics to Present Breast Cancer Drug Data at AACR 2026 WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) will present preclinical data on its experimental breast cancer drug candidate at t […]

Pennsylvania Horse Racing Association Announces 2026 Event Schedule HARRISBURG, PA — The Pennsylvania Horse Racing Association announced key dates for major horse racing events across the state in 2026, highlighting r […]

WHYY To Honor Malala Yousafzai With Lifelong Learning Award PHILADELPHIA, PA — WHYY will honor Nobel Peace Prize laureate Malala Yousafzai with its Lifelong Learning Award on Tuesday, April 14, 2026, at 5:30 p […]

Vasco Electronics Launches Web-Based Translation Platform WILMINGTON, DE — Vasco Electronics announced the launch of Vasco Audience, a web-based platform that provides simultaneous translation and live t […]

Vertex Makes Tax Software Available on Oracle Marketplace KING OF PRUSSIA, PA — Vertex Inc. (Nasdaq: VERX) said Tuesday its Vertex O Series Tax Engine and Indirect Tax Accelerator for Oracle enterprise r […]

Neuronetics Appoints Dan Reuvers as CEO, Succeeding Keith Sullivan MALVERN, PA — Neuronetics Inc. (Nasdaq: STIM) said it has appointed Dan Reuvers as president and chief executive officer, effective Monday, s […]

NRx Says FDA Finds No Bioequivalence Issues in Ketamine Filing WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) said the U.S. Food and Drug Administration has not identified bioequivalence deficiencies in i […]

Mineralys Grants Inducement Equity Awards to New Employee RADNOR, PA — Mineralys Therapeutics Inc. (Nasdaq: MLYS) said it granted stock options and restricted stock units to a new non-executive employee on M […]

The Lake That Covers a Town and Reveals a Story The surface of Marsh Creek Lake looks almost too calm in the early morning—just a slight ripple where a kayak cuts across the water, the paddle d […]

BTCS Revises 2026 Incentive Plan to Emphasize Profitability WAYNE, PA — BTCS Inc. (Nasdaq: BTCS) said it has revised its 2026 annual performance incentive program to place greater emphasis on gross profit, s […]

Aprea Reports 2025 Results, Early Data for APR-1051 Trial DOYLESTOWN, PA — Aprea Therapeutics Inc. (Nasdaq: APRE) reported its fourth-quarter and full-year 2025 financial results and said early clinical data f […]

Annovis Reports 2025 Results, Advances Buntanetap Trials MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) reported its 2025 financial results and said it advanced late-stage clinical development of its i […]

European Patent Office Grants Palvella Patent for QTORIN Rapamycin WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) said the European Patent Office has granted a patent covering its lead product candidate QTORIN 3 […]